Madrigal Pharmaceuticals Inc (NASDAQ: MDGL): How Can A Stock Be Up 7.83% Year To Date, But Still Loser
Madrigal Pharmaceuticals Inc (NASDAQ:MDGL)’s traded shares stood at 0.3 million during the last session, with the company’s beta value hitting -0.42. At the close of